MarginsXMarginsX
Home › Markets › Health Care › APLM

Apollomics Inc. (APLM)

APLM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$17.84
+0.91% on the day
Market cap
$51.7M
Micro cap
Revenue · 2025
$8.5M
Prior year not contiguous
Net income · 2025
-$10.9M
-128.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1944885/000119312526177357/0001193125-26-177357-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerAPLM on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001944885
SEC industry codePharmaceutical Preparations
Incorporated inCayman Islands

Financials · 2025

LineValue
Revenue$8.5M
Net income-$10.9M
Operating incomeNot in SEC XBRL data
Net margin-128.7%
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$3.3M
Total assets$6.7M
P/E (computed)Net income was not positive
P/S (computed)6.1×

Warning signs

Cash runway
3.8 months
$3.3M cash at December 31, 2025
Share count, 1 year
+99.0%
2025-04-03 to 2026-04-24
Going-concern doubt
Yes
20-F filed April 24, 2026
Insider net buying, 12 months
$8.3M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
20-F 2026-04-24
Cash and burn$3.3M cash; operating cash flow -$2.6M a quarter.Report 2025-12-31
Shares outstanding2,196,052 (2026-04-24); 1,103,348 a year earlier. the newest SEC cover-page count is from 2026-04-24; shares issued since then are not in these figures.Cover page 2026-04-24
Reverse splits, 3 years1; latest 1-for-100 on 2024-11-25Source 2024-11-25
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-09
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMarcum Asia CPAs LLP, New York, New York, United StatesPCAOB Form AP 2026-04-27
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $8.3M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$8.5M-$10.9M-$10.4M$3.3M$0$8.5M20-F 2026-04-24
FY 2024
2024-12-31
$0-$53.9M-$28.7M$9.8M$0$020-F 2025-04-03
FY 2023
2023-12-31
$0-$172.6M-$43.2M$32.1M$4.2M$020-F 2025-04-03
FY 2022
2022-12-31
$0-$240.8M-$42.8M$32.7MNo debt tags$020-F 2025-04-03
FY 2021
2021-12-31
$0-$94.8M-$43.3M$46.7MNo debt tags$020-F 2024-03-28
FY 2020
2020-12-31
$0-$74.8M-$35.7M$130.6MNo debt tags$020-F 2023-04-28

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-09-08
Latest annual report20-F2026-04-24
Latest quarterly / interim6-K2026-11-06

Source: SEC EDGAR submissions feed, 184 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-6.9%
1 month-17.1%
3 months+1.8%
Year to date-5.4%
1 year-15.6%
From 52-week high-36.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
APLMWApollomics Inc. Warrant$0.0105

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SDEVStablecoin Development Corporation$0.7055-9.55%$51.6M
QUCYQuantum Cyber N.V.$0.5850-7.58%$51.0M
CLNNClene Inc.$3.66-6.63%$52.7M
RFLRafael Holdings Inc.$0.9701-9.34%$50.6M
IBIOiBio Inc.$0.7067-3.42%$49.8M
CTORCitius Oncology Inc.$0.5350-6.76%$49.7M
HRTXHeron Therapeutics Inc.$0.2843-8.44%$54.1M
XLOXilio Therapeutics Inc.$7.70-3.08%$54.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier